S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
Critical asset just had biggest fall on record (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
Critical asset just had biggest fall on record (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
Critical asset just had biggest fall on record (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
Critical asset just had biggest fall on record (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Autozone stock price is still in the rally zone
Critical asset just had biggest fall on record (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
NASDAQ:CLVRW

Clever Leaves (CLVRW) Stock Price, News & Analysis

$0.04
0.00 (0.00%)
(As of 02/27/2024 ET)
Today's Range
$0.03
$0.04
50-Day Range
$0.01
$0.05
52-Week Range
$0.01
$0.06
Volume
38,642 shs
Average Volume
24,319 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CLVRW stock logo

About Clever Leaves Stock (NASDAQ:CLVRW)

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia.

CLVRW Stock Price History

CLVRW Stock News Headlines

See More Headlines
Receive CLVRW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
NASDAQ:CLVRW
Fax
N/A
Employees
400
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$18.57 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Andres Fajardo (Age 46)
    Co-Founder, CEO & Director
    Comp: $232.02k
  • Mr. Henry R. Hague III (Age 52)
    Chief Financial Officer
    Comp: $311.02k
  • Mr. Julian Wilches (Age 45)
    Chief Regulatory Officer
    Comp: $202.49k
  • Mr. Gustavo Escobar
    Chief Operating Officer
  • Ms. Marta Pinto Leite
    General Counsel & Corporate Secretary
  • Mr. Andrew Miller
    Head of Business Development
  • Mr. Camilo Bohorquez
    Head of Colombia
  • Ms. Caroline Kliess
    Managing Director of Germany
  • Jackie Keshner
    Investor Relations Executive














CLVRW Stock Analysis - Frequently Asked Questions

How have CLVRW shares performed in 2024?

Clever Leaves' stock was trading at $0.0177 on January 1st, 2024. Since then, CLVRW stock has increased by 115.8% and is now trading at $0.0382.
View the best growth stocks for 2024 here
.

How do I buy shares of Clever Leaves?

Shares of CLVRW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLVRW) was last updated on 2/28/2024 by MarketBeat.com Staff